Paraffin Oil or Coconut Oil in Acute Aluminum Phosphide Poisoning

Overview

The aim of the present study is to evaluate safety and efficacy of gastric lavage with paraffin oil or gastric lavage with coconut oil in management of acute Aluminum phosphide poisoning.

Full Title of Study: “Gastric Lavage With Paraffin Oil or Coconut Oil in Management of Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Investigator)
  • Study Primary Completion Date: June 30, 2021

Detailed Description

60 patients will be randomly assigned as control groups, paraffin group, and coconut group in a 1:1:1 ratio (30 patients in each group). Inclusion criteria: – Patients with symptomatic acute aluminum phosphide poisoning – Age is more than 12 years of both gender – Patients presenting within 6 hours post-ingestion of aluminum phosphide (Papade and Vanjari, 2019). The diagnosis is made on the basis of: 1. The suggestive clinical manifestations due to and following shortly after a single exposure to aluminum phosphide. 2. Reliable identification of the compound based on the container brought by patient attendants. 3. Biochemical detection of phosphine gas in gastric aspirate (silver nitrate test). – Group (I): Gastric lavage with saline and sodium bicarbonate 8.4% then aspiration will be done after 3-5 min through nasogastric tube (Control group) – Group (II): Gastric lavage will be initiated with 50 mL of Paraffin oil and 50 mL of sodium bicarbonate solution 8.4%, then aspiration will be done after 3-5 min through nasogastric tube (Paraffin group). – Group (III): Gastric lavage will be initiated with 50 ml coconut oil and 50 ml sodium bicarbonate 8.4 % then aspiration will be done after 3-5 min through nasogastric tube (Coconut group). – All patients will continue to receive the standard supportive treatment according to Tanta University Poison Control Center protocol, which is determined by the attending physician who maintains clinical responsibility for all patients. Conventional standard treatment included using inotropes, fluids and electrolytes resuscitation, intubation, mechanical ventilation and antiarrhythmic agents if indicated.

Interventions

  • Other: gastric lavage with paraffin oil and bicarbonate
    • Gastric lavage will be initiated with 50 mL of Paraffin oil and 50 mL of sodium bicarbonate solution 8.4%, then aspiration will be done after 3-5 min through nasogastric tube
  • Other: gastric lavage with coconut oil and bicarbonate
    • Gastric lavage will be initiated with 50 ml coconut oil and 50 ml sodium bicarbonate 8.4 % then aspiration will be done after 3-5 min through nasogastric tube
  • Drug: standard treatment
    • inotropes as levophid, fluids and electrolytes , endotracheal intubation, mechanical ventilation and antiarrhythmic agents as Magnesium sulfate
  • Other: gastric lavage with saline and bicarbonate
    • Gastric lavage with saline and sodium bicarbonate 8.4% then aspiration will be done after 3-5 min through nasogastric tube

Arms, Groups and Cohorts

  • Other: control group
    • gastric lavage with saline and bicarbonate and standard treatment :inotropes as levophid, fluids and electrolytes , endotracheal intubation, mechanical ventilation and antiarrhythmic agents as Magnesium sulfate
  • Active Comparator: paraffin group
    • gastric lavage with paraffin oil and bicarbonate and standard treatment :inotropes as levophid, fluids and electrolytes , endotracheal intubation, mechanical ventilation and antiarrhythmic agents as Magnesium sulfate
  • Active Comparator: coconut group
    • gastric lavage with coconut oil and bicarbonate and standard treatment :inotropes as levophid, fluids and electrolytes , endotracheal intubation, mechanical ventilation and antiarrhythmic agents as Magnesium sulfate

Clinical Trial Outcome Measures

Primary Measures

  • death
    • Time Frame: 72 hours

Participating in This Clinical Trial

Inclusion Criteria

  • • Patients with symptomatic acute aluminum phosphide poisoning – Age is more than 12 years of both gender – Patients presenting within 6 hours post-ingestion of aluminum phosphide Exclusion Criteria:

  • • Patients less than 12 years of age – Pregnant and lactating women. – Patients with ingestion or exposure to other substances in addition to aluminum phosphide. – Patients with other major medical conditions (e.g. cardiovascular disease, diabetes mellitus, renal or hepatic failure).

Gender Eligibility: All

Minimum Age: 12 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Tanta University
  • Provider of Information About this Clinical Study
    • Principal Investigator: samah maher, faculty of medicine,tanta university,Tanta Elgeesh street,qism 2,Egypt – Tanta University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.